Ginkgo Bioworks (NYSE:DNA) Cut to "Market Perform" at William Blair
Ginkgo Bioworks (NYSE:DNA – Get Rating) was downgraded by William Blair from an “outperform” rating to a “market perform” rating in a research report issued on Thursday, Briefing.com reports. Other research analysts also recently issued reports about the stock. Raymond James reduced their price objective on shares of Ginkgo Bioworks from $6.00 to $5.00 and […]